glp-1 drugs made from America's Poison Centers GLP-1-based therapies for type 2

Most non-users concerned over side effects, costs of GLP-1s While GLP-1 medications have been a positive experience for many, there are still potential concerns for current and potential users to worry about

[DOI] [PMC free article] [PubMed] [Google Scholar] [127].Barrera JG, Sandoval DA, D'Alessio DA, Seeley RJ, GLP-1 and energy balance: an integrated model of short-term and long-term control, Nature reviews

The approved dose of Wegovy is 2.4 mg, so doses of 1.7mg should be flagged for evaluation

Suboptimal obesity treatments can increase the risk of weight cycling, sarcopenia with aging, compromised quality of life, and reduced functional health [21]

doi: 10.1038/modpathol.2014.113 74 HeLZhangSZhangXLiuRGuanHZhangH

The control (C) comprised individuals who received either a placebo or another active comparator